ISPOR - Cheryl Neslusan

Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non–Small Cell Lung Cancer in Jordan

Sep 1, 2024, 00:00 AM

Cheryl Neslusan

Jun 11, 2019, 09:02 AM

First Name : Cheryl

Last Name : Neslusan

Degrees : PhD

Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non–Small Cell Lung Cancer in Jordan

Sep 1, 2024, 00:00 AM

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now